SpectraCure AB (publ) (STO:SPEC)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.8120
+0.0020 (0.25%)
May 13, 2025, 1:55 PM CET
-72.84%
Market Cap 78.68M
Revenue (ttm) n/a
Net Income (ttm) -23.00M
Shares Out 97.13M
EPS (ttm) -0.24
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 20,763
Average Volume 233,429
Open 0.8130
Previous Close 0.8100
Day's Range 0.7710 - 0.8140
52-Week Range 0.7000 - 5.1100
Beta 0.42
RSI 24.54
Earnings Date May 16, 2025

About SpectraCure AB

SpectraCure AB (publ) engages in the development of cancer treatment system. It develops Q-PRO, a laser device; and IDOSE software with interstitial photodynamic therapy system for the treatment of prostate cancer. The company was incorporated in 2003 and is based in Lund, Sweden. [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2003
Employees 13
Stock Exchange Nasdaq Stockholm
Ticker Symbol SPEC
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.